Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population

This publication has 27 references indexed in Scilit:

• Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia
  The American Journal of Cardiology, 2004
• Endothelial Dysfunction Induced by Hyperhomocyst(e)inemia
  Circulation, 2003
• The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA)
  Clinical Nutrition, 2003
• Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke
  Atherosclerosis, 2001
• Endogenous Nitric Oxide Synthase Inhibitor
  Circulation, 1999
• Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction
  Circulation, 1998
• Stroke Risk Factors and Stroke Prevention
  Seminars in Neurology, 1998
• NITRIC OXIDE SYNTHASE: Role in the Genesis of Vascular Disease
  Annual Review of Medicine, 1997
• Relationship Between Insulin Resistance and Endothelium-Dependent Vascular Relaxation in Patients With Essential Hypertension
  Hypertension, 1997
• Reduced plasma L-arginine in hypercholesterolaemia
  The Lancet, 1992